Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent

The American Journal of Medicine

Volumn 85, Issue 2, 1988, Pages 134-138

  Curtis, John J ^a   Luke, Robert G ^a   Jones, Patsy ^a   Diethelm, Arnold G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT;

CLINICAL ARTICLE; DRUG THERAPY; ETIOLOGY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; SODIUM EXCRETION;

ADULT; AZATHIOPRINE; COMPARATIVE STUDY; CYCLOSPORINS; DIET, SODIUM-RESTRICTED; FEMALE; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; PLASMA VOLUME; SODIUM; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023793171     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(88)80331-0     Document Type: Article

References (40)

1. Hypertension after successful renal transplantation
2. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine
3. Cyclosporine associated chronic nephropathy
4. Acute tubular necrosis and arterial hypertension in renal transplant patients treated with cyclosporine
5. Hypertension after renal transplantation: a comparison of cyclosporine and conventional immunosuppression
6. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis
7. New onset of hypertension following cardiac transplantation: a preliminary report and analysis
8. Side effects of cyclosporine in patients not undergoing transplantation
9. Cyclosporine in therapeutic doses increases renal allograft vascular resistance
10. Renal dysfunction in animal models of cyclosporine toxicity
11. Renal vascular tone in essential and secondary hypertension
12. Reactivity of renal and systemic circulation to vasoconstrictor agents in normotensive and hypertensive subjects
13. Cyclosporine nephrotoxicity without major organ transplantation
14. Side effects and safety of Sandimmune in long-term treatment of renal transplant patients
15. Experimental cyclosporine A nephrotoxicity: a summary of the International Workshop
16. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin in normal human subjects
17. Plasma volume in men with essential hypertension
18. The ColoradoPittsburgh cadaveric renal transplantation study with cyclosporine
19. Cyclosporine induced remission of relapsing nephrotic syndrome in children (abstr)
20. Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2
21. The effect of cyclosporine of renal function in newly diagnosed diabetics
22. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset
23. Cyclosporine in cadaveric renal transplantation: one year follow-up of a multicentre trial
24. Cyclosporine nephrotoxicity
25. Occlusive arterial disease following renal transplantation
26. Combined 15th Report on Regular Dialysis and Transplantation in Europe, 1984
27. Post-transplant hypertension: studies of cortical blood flow and the renal pressor system
28. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys
29. Mechanisms of post transplantation hypertension
30. Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients
31. Cyclosporine-associated chronic nephropathy
32. Acute cyclosporine A nephrotoxicity in rats: which role for the renin-angiotensin system and glomerular prostaglandins
33. Effect of cyclosporine on the renin-angiotensin-aldosterone system
34. Effect of cyclosporine administration on renal hemodynamics in conscious rats
35. Glomerulotubular function in cyclosporine A treated rats
36. The haemodynamic effects of cyclosporin A in sheep (abstr)
37. Suppression of plasma renin activity by cyclosporine
38. 2 production (abstr)
39. Mechanism of essential hypertension